IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus

Nadera J. Sweiss, Ronghai Bo, Reena Kapadia et al. · 2010

Read IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus by Nadera J. Sweiss, Ronghai Bo, Reena Kapadia et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012280.txt.

Description

Nadera Sweiss, Ronghai Bo, Reena Kapadia, and co-authors weighed a disputed antibody test in lupus patients, in PLOS ONE in 2010. Antiphospholipid antibodies can drive dangerous clots, but whether the IgA class of these antibodies counts has been argued for years, leaving its test in limbo. The authors reasoned that if these antibodies truly contribute, patients carrying them should suffer more clotting events.

Comparing lupus patients with and without the IgA antibodies, they found the carriers faced increased risk of blood clots in vessels and organs. Evidence tied to real events, not just lab values, is what moves a test into guidelines. For lupus care, settling this question changes which patients get watched or treated for clot risk.

Catalog record

CREATORNadera J. Sweiss, Ronghai Bo, Reena Kapadia et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012280

Browse the full library · About the Tower of Babel